BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35292485)

  • 1. Feasibility and safety of physical exercise in men with prostate cancer receiving androgen deprivation therapy and radiotherapy: a study protocol.
    Bressi B; Iotti C; Cagliari M; Cavuto S; Fugazzaro S; Costi S
    BMJ Open; 2022 Mar; 12(3):e048854. PubMed ID: 35292485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and Safety of Physical Exercise to Preserve Bone Health in Men With Prostate Cancer Receiving Androgen Deprivation Therapy: A Systematic Review.
    Cagliari M; Bressi B; Bassi MC; Fugazzaro S; Prati G; Iotti C; Costi S
    Phys Ther; 2022 Mar; 102(3):. PubMed ID: 34972863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of aerobic- and resistance-emphasised exercise on cardiometabolic health and quality of life in men receiving androgen deprivation therapy for prostate cancer: Protocol for a feasibility trial.
    Murphy K; Kehoe B; Denieffe S; Hacking D; Fairman CM; Harrison M
    Contemp Clin Trials; 2024 Jan; 136():107388. PubMed ID: 37972755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical exercise for bone health in men with prostate cancer receiving androgen deprivation therapy: a systematic review.
    Bressi B; Cagliari M; Contesini M; Mazzini E; Bergamaschi FAM; Moscato A; Bassi MC; Costi S
    Support Care Cancer; 2021 Apr; 29(4):1811-1824. PubMed ID: 33119791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Individualized Diet and Exercise Adherence Pilot Trial (IDEA-P) in prostate cancer patients undergoing androgen deprivation therapy: study protocol for a randomized controlled trial.
    Focht BC; Lucas AR; Grainger E; Simpson C; Thomas-Ahner JM; Clinton SK
    Trials; 2014 Sep; 15():354. PubMed ID: 25199619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer.
    Newton RU; Taaffe DR; Spry N; Gardiner RA; Levin G; Wall B; Joseph D; Chambers SK; Galvão DA
    BMC Cancer; 2009 Jun; 9():210. PubMed ID: 19563641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy.
    Lee CE; Leslie WD; Lau YK
    BMC Cancer; 2012 Mar; 12():103. PubMed ID: 22436542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supported exercise TrAining for Men wIth prostate caNcer on Androgen deprivation therapy (STAMINA): study protocol for a randomised controlled trial of the clinical and cost-effectiveness of the STAMINA lifestyle intervention compared with optimised usual care, including internal pilot and parallel process evaluation.
    McNaught E; Reale S; Bourke L; Brown JE; Collinson M; Day F; Hewison J; Farrin AJ; Ibeggazene S; Innes AQ; Mason E; Meads D; Scope A; Taylor C; Taylor SJ; Turner RR; Rosario DJ;
    Trials; 2024 Apr; 25(1):257. PubMed ID: 38610058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutrition therapy with high intensity interval training to improve prostate cancer-related fatigue in men on androgen deprivation therapy: a study protocol.
    Baguley BJ; Skinner TL; Leveritt MD; Wright OR
    BMC Cancer; 2017 Jan; 17(1):1. PubMed ID: 28049525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial.
    Owen PJ; Daly RM; Livingston PM; Mundell NL; Dalla Via J; Millar JL; Fraser SF
    Trials; 2017 Oct; 18(1):451. PubMed ID: 28974267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group-based exercise in daily clinical practice to improve physical fitness in men with prostate cancer undergoing androgen deprivation therapy: study protocol.
    Østergren P; Ragle AM; Jakobsen H; Klausen TW; Vinther A; Sønksen J
    BMJ Open; 2016 Jun; 6(6):e011460. PubMed ID: 27357198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II RCT and economic analysis of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.
    Alibhai SM; Santa Mina D; Ritvo P; Sabiston C; Krahn M; Tomlinson G; Matthew A; Segal R; Warde P; Durbano S; O'Neill M; Culos-Reed N
    BMC Cancer; 2015 Apr; 15():312. PubMed ID: 25908311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT.
    Alibhai SMH; Ritvo P; Santa Mina D; Sabiston C; Krahn M; Tomlinson G; Matthew A; Lukka H; Warde P; Durbano S; O'Neill M; Culos-Reed SN
    BMC Cancer; 2018 Oct; 18(1):1031. PubMed ID: 30352568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of exercise in the management of adverse effects of androgen deprivation therapy for prostate cancer: a rapid review.
    Edmunds K; Tuffaha H; Scuffham P; Galvão DA; Newton RU
    Support Care Cancer; 2020 Dec; 28(12):5661-5671. PubMed ID: 32699997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for GET FIT Prostate: a randomized, controlled trial of group exercise training for fall prevention and functional improvements during and after treatment for prostate cancer.
    Winters-Stone KM; Li F; Horak F; Dieckmann N; Hung A; Amling C; Beer TM
    Trials; 2021 Nov; 22(1):775. PubMed ID: 34742325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.
    Alibhai SMH; Santa Mina D; Ritvo P; Tomlinson G; Sabiston C; Krahn M; Durbano S; Matthew A; Warde P; O'Neill M; Timilshina N; Segal R; Culos-Reed N
    BMC Cancer; 2019 Jan; 19(1):2. PubMed ID: 30606137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate Cancer Survivorship Essentials for men with prostate cancer on androgen deprivation therapy: protocol for a randomised controlled trial of a tele-based nurse-led survivorship care intervention (PCEssentials Hormone Therapy Study).
    Green A; Newton RU; Smith DP; Tuffaha H; Galvão DA; Heathcote P; Patel MI; Christie D; Egger S; Sara SA; Heneka N; Chambers SK; Dunn J
    BMJ Open; 2024 Mar; 14(3):e084412. PubMed ID: 38521521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of a 12-month supervised, intensive resistance, aerobic and impact exercise intervention on muscle strength in prostate cancer patients undergoing anti-hormone therapy: Study protocol for the randomized, controlled Burgdorf study.
    Reimer N; Hafke R; Wrensch M; Horst P; Bloch W; Hahn T; Kirchhoff A; Kluck KL; Stein J; Baumann FT
    Contemp Clin Trials; 2022 Mar; 114():106685. PubMed ID: 35065281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of walking exercise in promoting cognitive-psychosocial functions in men with prostate cancer receiving androgen deprivation therapy.
    Lee CE; Kilgour A; Lau YK
    BMC Cancer; 2012 Jul; 12():324. PubMed ID: 22846379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: rationale and design.
    Thorsen L; Nilsen TS; Raastad T; Courneya KS; Skovlund E; Fosså SD
    BMC Cancer; 2012 Mar; 12():123. PubMed ID: 22458865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.